Neuropsychiatric Disease and Treatment: 20 Years on.
作者信息
Pinder Roger M
机构信息
Editor in Chief, Neuropsychiatric Disease and Treatment, York, UK.
出版信息
Neuropsychiatr Dis Treat. 2025 Mar 1;21:463-464. doi: 10.2147/NDT.S520367. eCollection 2025.
Abstract
摘要
相似文献
1
Neuropsychiatric Disease and Treatment: 20 Years on.
Neuropsychiatr Dis Treat. 2025 Mar 1;21:463-464. doi: 10.2147/NDT.S520367. eCollection 2025.
2
A review and update on the diagnosis and treatment of neuropsychiatric Wilson disease.
Expert Rev Neurother. 2019 Nov;19(11):1117-1126. doi: 10.1080/14737175.2019.1645009. Epub 2019 Jul 25.
3
Treatment of Neuropsychiatric Symptoms in Parkinson's Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial.
J Geriatr Psychiatry Neurol. 2025 May;38(3):223-231. doi: 10.1177/08919887241281066. Epub 2024 Sep 3.
4
Neuropsychiatric behaviors in the MPTP marmoset model of Parkinson's disease.
Can J Neurol Sci. 2010 Jan;37(1):86-95. doi: 10.1017/s0317167100009707.
5
Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study.
Dement Geriatr Cogn Disord. 2012;34(5-6):319-27. doi: 10.1159/000342824. Epub 2012 Dec 3.
6
Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies.
Continuum (Minneap Minn). 2022 Oct 1;28(5):1314-1332. doi: 10.1212/CON.0000000000001151.
7
Evaluation of Neuropsychiatric Effects of Montelukast-Levocetirizine Combination Therapy in Children with Asthma and Allergic Rhinitis.
Children (Basel). 2023 Jul 28;10(8):1301. doi: 10.3390/children10081301.
8
A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
J Am Med Dir Assoc. 2015 Apr;16(4):316-22. doi: 10.1016/j.jamda.2014.11.002. Epub 2014 Dec 15.
9
Anosognosia in Early- and Late-Onset Dementia and Its Association With Neuropsychiatric Symptoms.
Front Psychiatry. 2021 May 13;12:658934. doi: 10.3389/fpsyt.2021.658934. eCollection 2021.
10
Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus.
Am J Med. 2000 Dec 1;109(8):628-34. doi: 10.1016/s0002-9343(00)00603-3.
本文引用的文献
1
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534. doi: 10.2147/NDT.S225643. eCollection 2020.
2
Alcohol and Dementia - What is the Link? A Systematic Review.
Neuropsychiatr Dis Treat. 2020 Jan 9;16:87-99. doi: 10.2147/NDT.S198772. eCollection 2020.
3
Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder.
Neuropsychiatr Dis Treat. 2018 Dec 3;14:3329-3337. doi: 10.2147/NDT.S188340. eCollection 2018.
4
Sleep problems in university students - an intervention.
Neuropsychiatr Dis Treat. 2017 Jul 26;13:1989-2001. doi: 10.2147/NDT.S142067. eCollection 2017.
5
Moderate alcohol consumption and cognitive risk.
Neuropsychiatr Dis Treat. 2011;7:465-84. doi: 10.2147/NDT.S23159. Epub 2011 Aug 11.
6
Sleep deprivation: Impact on cognitive performance.
Neuropsychiatr Dis Treat. 2007;3(5):553-67.
7
Enhancing central noradrenergic function in depression: is there still a place for a new antidepressant?
Neuropsychiatr Dis Treat. 2005 Mar;1(1):3-7. doi: 10.2147/nedt.1.1.3.52293.
Zotero 插件